Conference abstract · 18 Jul 2016
Conference abstractPublished 22 Jun 2015
Why wait till it is too late?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In the latest statistical records, Australia and the United States are among the countries in the World where, apart from lung cancer more men die from prostate cancer than from any other cancer. The reason for this is the lack of a diagnostic test being offered that is 100% reliable. The PSA test offers an accuracy of less than 50%, so why bother with it? There is a test that offers, on blinded trials, a sensitivity of 100% as all prostate cancers were correctly diagnosed. However the specificity was 99.2% as there were 3 false positives in 377 samples. Tests on transgenic (TRAMP) mice have correctly identified the affected mice from the controls at 3 weeks. No other test can do this before 10 weeks of age. False positives in breast cancer found using this technique have been found to be not false, just earlier than could be detected by mammography. So those false positives may be correct only in earlier diagnoses, only time will tell. In the last blinded set of 30 samples, perineural invasions had occurred in 20 of the cases and 1 of these had a lymphatic invasion as well. These men waited too long for diagnosis. The test uses low angle diffraction of skin biopsies, the skin biopsy being taken from the stomach or buttocks using a 3mm Keyes punch. Such biopsies do not cause any problems and are relatively non-invasive whereas biopsies of the prostate cause major infections in many cases. So this test could be run from age 30 or earlier on an annual or biennial routine test. If a prostate cancer is found, it can be located by an MRI. It will be at an early stage and can be removed, mostly without surgery. Since the change in the diffraction pattern is only present while the cancer is present, a further diffraction test can be used to verify the success of the treatment when concluded, that is 100% of the cancer has been removed. This clears the way ahead for the patient. Such a test would eliminate most if not all deaths from this cancer. So my question, what are we waiting for?
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 27 Oct 2021
The influence of the first coronavirus wave on the two-week-wait head and neck cancer referrals to a London hospital
Short communication · 17 Aug 2020
The efficiency of two-week wait referrals for suspected head and neck cancer
Conference abstract · 24 Jan 2020
Comparative study on how low cost in clinic activities increases patient satisfaction during waiting time at OPD in selected oncology clinic
Short communication · 23 Jul 2018
Comparative study on how low cost in Clinic Activities increases patient satisfaction during waiting time at OPD in selected Oncology Clinic
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Veronica J James”

